Abstract
Patients with bipolar disorder (BD) show higher immuno-inflammatory setpoints, with in vivo alterations in white matter (WM) microstructure and post-mortem infiltration of T cells in the brain. Cytotoxic CD8+ T cells can enter and damage the brain in inflammatory disorders, but little is known in BD. Our study aimed to investigate the relationship between cytotoxic T cells and WM alterations in BD. In a sample of 83 inpatients with BD in an active phase of illness (68 depressive, 15 manic), we performed flow cytometry immunophenotyping to investigate frequencies, activation status, and expression of cytotoxic markers in CD8+ and tested for their association with diffusion tensor imaging (DTI) measures of WM microstructure. Frequencies of naïve and activated CD8+ cell populations expressing Perforin, or both Perforin and Granzyme, negatively associated with WM microstructure. CD8+ Naïve cells negative for Granzyme and Perforin positively associates with indexes of WM integrity, while the frequency of CD8+ memory cells negatively associates with index of WM microstructure, irrespective of toxins expression. The resulting associations involve measures representative of orientational coherence and myelination of the fibers (FA and RD), suggesting disrupted oligodendrocyte-mediated myelination. These findings seems to support the hypothesis that immunosenescence (less naïve, more memory T cells) can detrimentally influence WM microstructure in BD and that peripheral CD8+ T cells may participate in inducing an immune-related WM damage in BD mediated by killer proteins.
Similar content being viewed by others
Introduction
Bipolar disorder (BD) has been consistently associated with alterations in the immune system1. Evidence suggests a condition of systemic low-grade inflammation due to decreased adaptive and increased innate immunity, with higher levels of circulating cytokines, higher macrophage/monocyte inflammatory activation patterns, and higher neutrophils to lymphocyte counts; and with a dynamic pattern of premature immunosenescence and partial T cell defect starting early in adolescence, involving a reduction of naïve T cells and an expansion of memory and senescent T cells2,3,4,5,6. Quantitative analysis of circulating inflammatory markers, such as cytokines and chemokines, suggested persistent low-grade inflammation7,8. Measured in peripheral blood, these markers of altered immuno-inflammatory setpoints parallel activation of microglia and disruption of white matter (WM) integrity in the brain9,10. Moreover, post-mortem studies documented abnormal T and B cell infiltration of brain tissue in subgroups of patients with mood disorders, but their possible pathogenetic role is largely unknown11.
Altered WM microstructure in circuitries critical for emotional and cognitive processing is a core biological correlate of BD12. In vivo diffusion tensor imaging (DTI) consistently showed higher mean diffusivity of water (MD), with higher diffusivity perpendicular to the main axis of fibers (radial diffusivity, RD, mainly associated with myelination), and lower diffusivity along the main axis (axial diffusivity, AD, mainly associated with the axonal microstructure), resulting in lower preferential diffusivity along WM tracts (fractional anisotropy, FA). These measures reflect myelination, orientational coherence, and microtubular axonal structure of fibers13,14,15. In BD, they associate with genetic risk16,17, with environmental stressors increasing the disorder risk18, with markers of and with gene variants affecting the course and outcome of the illness19,20,21; and underpin highly relevant clinical phenotypes such as impulsivity and suicide22, cognitive performance23,24, and response to treatment25.
A growing literature suggests that the immune system plays a core role in maintaining brain homeostasis, with both adaptive and innate immune support, ensured by cell trafficking across the blood–brain barrier, being essential for brain maintenance and repair in healthy conditions and disrupted in brain disorders including BD26,27. It can be hypothesized that the circulating immune cell composition and activation status, reflecting individual variation and altered immunophenotyping associated with BD, could also be associated with altered brain phenotypes, such as disrupted WM microstructure. Studies in the field are in its infancy, but previous findings by our group confirm that the balance between cell subsets might play a role in the maintenance of the structural brain integrity in BD: circulating Th17 cells correlated with higher FA, while regulatory FOXP3+ cells correlated with higher RD and MD, and with lower fMRI neural responses in the right dorsolateral prefrontal cortex2, a phenotype associated with bipolar depression28; higher circulating cytokine-producing NK cells (TNFα, INFγ, and GMCSF) were fostered by ongoing lithium treatment and directly correlated with better FA, and inversely with RD and MD, also partially mediating the known benefits from lithium on WM29,30; levels of the cytokines TNF-α, IL-8, IFN-γ, and IL-10 associated negatively with AD and positively with RD, suggesting that markers of peripheral immune-inflammatory activation negatively affect the integrity of myelin sheaths31.
However, the majority of circulating leukocyte populations associated with BD has not yet been studied in this perspective. Among them, cytotoxic T lymphocytes (CTLs) (CD3+CD8+) play a crucial role in the adaptive immune response, and stimulation by antigens throughout life markedly favors their switching towards senescent phenotypes thus contributing to low-grade inflammation: it is suggested that a better characterization of their phenotype and functions could be pivotal to prevent immune-related medical conditions32. In BD, the few available studies reported either no difference in the CD8+ compartment in respect to healthy controls33; or a general decrement in the cytotoxic T cells compartment34,35, a decrease in replicating/proliferating (CD71+) cells36, and an increase in proportions of late-differentiated cells (CD28−CD27−) associated both, with age, and with recurrence of illness episodes37. A single study showed a general depletion of the CD8+ compartment, and positively associated activated CD8+IFNγ+ and activated CD8+CD28−CD45RA+ cells with increased FA and decreased RD, in corona radiata and corpus callosum, during manic illness episodes, and not during depression or euthymia38.
Cytotoxic CD8+ T cells can enter the brain, and are considered important effector cells contributing to neuronal damage in inflammatory and degenerative brain disorders39. In BD, they appear to be more activated and senescent, their proportion also influencing WM integrity in some illness phases, but data on their activation status and expression of cytotoxic markers are lacking.
The present study aims to investigate a possible specific involvement of the lymphocytes cytotoxic compartment associated to previously reported WM alterations. To do that, we aimed at associating, with a comprehensive and systematic approach, TBSS measures of WM integrity with CD8+, NK, and Tγδ cells immunophenotyping data of 83 patients with an active illness episode in course of BD.
Methods
Participants
All participants to this study were volunteers: each subject was provided with a complete description of the study and gave written informed consent for participation. All the experimental protocols and procedures contributing to this work comply with the ethical standards, relevant guidelines and regulations of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. The study was approved by the local ethical committee of San Raffaele Hospital.
Out of 102 screened inpatients with BD, consecutively admitted to the Center for Mood Disorders of the San Raffaele Hospital, 83 biologically unrelated inpatients (F 55; M 28) with a diagnosis of Bipolar Disorder Type I (DSM-5 criteria) were included in the study: 68 patients had a depressive and 15 a manic episode. All the patients enrolled underwent a psychiatric interview and a physical examination performed by a resident psychiatrist of the ward. The tests performed for the diagnostic evaluation were the nationally validated versions of the Hamilton depression rating scale (HDRS)40, young mania rating scale (YMRS)41, and beck depression inventory (BDI)42. Inclusion criteria were: to agree to participate; age between 18 and 65 years; signed informed consent. Exclusion criteria were: other psychiatric diagnoses, current pregnancy, history of epilepsy, major neurological or physical illnesses, previous cranial and/or cerebral injuries, autoimmune disorders, intellectual disability, current inflammatory conditions (e.g., infections, viruses) or anti-inflammatory drugs use (steroidal and non-steroidal), and history of alcohol and/or substance abuse in the lasts 6 months. Nicotine was not considered an abuse substance within the exclusion criteria.
Laboratory methods
The immunophenotype of T cytotoxic lymphocyte subpopulations was obtained by flow cytometry on each participant's isolated peripheral blood mononuclear cells (PMBCs). The blood sampling was performed in the morning (8.00–9.00 AM). PBMCs were immediately (within 1 h from the blood collection) isolated by density gradient centrifugation with Ficoll-Paque PLUS (GE Healthcare, Uppsala, Sweden), and cryo-preserved in a freezing medium with 90% Fetal Bovine Serum (FBS) (Thermo Fisher) and 10% dimethyl sulfoxide (DMSO) in liquid nitrogen at − 192° until flow cytometry. Both surface and intracellular stainings were performed to characterize the cytotoxic activity of T-lymphocytes (CD8 +), T ϒδ lymphocytes and NK cells. After morphological characterization, we used the following gating strategy: the expression of CD3 and CD56 markers were used to identify and gate both T-lymphocytes (CD3+CD56−) and NK cells (CD3−CD56+). On CD3+CD56− gated cells, the relative expression of CD4 and CD8 was used to identify CD8+ lymphocytes. Moreover, the relative expression of Vd1 and Vd2 was used to identify T ϒδ lymphocytes (CD3+Vd1Vd2+). On CD8+ T cells, further characterization of primed (memory) cells was performed using CD27 and CD45RA markers: naϊve cells express both cell surface glycoproteins (CD45RA+CD27+), central memory cells express CD27 but not CD45RA (CD45RA−CD27+), effector memory (EM) cells are double negative (CD45RA−CD27−), and terminally differentiated effector memory cells re-express CD45RA (TEMRA) cells (CD45RA+CD27−). Finally, granzyme and perforin relative expression was analyzed on NK cells, differentially primed CD8+ T-cells, and T ϒδ lymphocytes to evaluate the activation of cytotoxic mechanisms. Blood was sampled in the morning on the same day of the MRI study. Cell frequencies were compared among the two groups of patients with a manic or a depressive episode by analyzing the homogeneity of slopes in the context of a generalized linear model (GLZM), with an identity link function43. Parameter estimates were obtained with iterative re-weighted least squares maximum likelihood procedures. The significance of the effects was calculated with the likelihood ratio (LR) statistic, which provides the most asymptotically efficient test known44,45.
Image acquisition and analysis
DWI was executed using SE Eco-planar imaging (EPI) and the following parameters for the first scanner TR/TE = 8753.89/58 ms, FoV (mm) 231.43 (ap), 126.50 (fh), 240.00 (rl); acquisition matrix 2.14 × 2.71 × 2.31; 55 contiguous, 2.3 mm thick axial slices reconstructed with in-plane pixel size 1.88 × 1.87 mm; SENSE acceleration factor = 2; 1 b0 and 35 non-collinear directions of the diffusion gradients; b value = 900 s/mm2; and the following for the second Philips scanner TR/TE = 5900/78 ms, FoV (mm) 240 (ap), 129 (fh), 232 (rl); acquisition matrix 2.14 × 2.73 × 2.30; 56 contiguous, 2.3 mm thick axial slices reconstructed with in-plane pixel size 1.88 × 1.88 × 2.30 mm; SENSE acceleration factor = 2; 1 b0 and 40 non-collinear directions of the diffusion gradients; b value = 1000 s/mm2. Fat saturation was performed to avoid chemical shift artifacts.
DTI analysis and tensor calculations were carried out using the "Oxford Center for Functional Magnetic Resonance Imaging of the Brain Software Library" (FSL 6.0; www.fmrib.ox.ac.uk/fsl/index.html)46.
Each DWI volume was affine registered to the T2-weighted b = 0 volume using FLIRT (FMRIB's Linear Image Registration Tool). Then, correction for motion between scans and residual eddy-current distortions present in the diffusion-weighted images was performed. After removal of nonbrain tissue, least-square fits were performed to estimate the FA, eigenvector, and eigenvalue maps. MD was defined as the mean of all three eigenvalues (λ1 + λ2 + λ3)/3, AD as the principal diffusion eigenvalue (λ1), and RD as the mean of the second and third eigenvalues (λ2 + λ3)/2. Next, all individuals' volumes were skeletonized and transformed into a common space as used in Tract-Based Spatial Statistics47. Briefly, all volumes were nonlinearly warped to the FMRIB58_FA template supplied with FSL (http://www.fmrib.ox.ac.uk/fsl/tbss/FMRIB58_FA.html) and normalized to the montreal neurological institute (MNI) space, by use of local deformation procedures performed by FMRIB's non-linear image registration tool (FNIRT). Next, a mean FA volume of all subjects was generated and thinned to create a mean FA skeleton representing the centers of all common tracts. We thresholded and binarized the mean skeleton at FA > 0.20 to reduce the likelihood of partial voluming in the borders between tissue classes. Individual FA values were warped onto this mean skeleton mask. The resulting tract invariant skeletons for each participant were fed into voxel-wise permutation-based cross-subject statistics. Similar warping and analyses were used on MD, AD, and RD data.
We accounted for the effects of nuisance covariates that could influence WM microstructure: age48, sex49, lithium treatment30, phase of illness, and MR scanner. MRI scan variable has been created as a dichotomous variable, which can assume one of two possible values in accordance with the MRI scan used for each subject. This has been done in order to control for the potential confounding effect of using two different scanners in the analyses. Voxel-wise DTI analyses were performed using nonparametric permutation-based testing as implemented in Randomise in FSL. We tested for linear effects of the concentration of each cellular subpopulation on FA, MD, AD, and RD across the WM skeleton with general linear models (GLM). Threshold-free cluster enhancement (TFCE) was used to avoid defining arbitrary cluster-forming thresholds and smoothing levels. The data were tested against an empirical null distribution generated by 5000 permutations for each contrast, thus providing statistical maps fully corrected for multiple comparisons across space. Corrected p < 0.05 was considered significant.
To better understand a possible effect of the illness phase (manic or depressed), we also performed the same DTI analyses in the subsample of sixty-eight depressed patients, excluding those with a manic episode, and maintaining age, sex, lithium treatment, and MR scanner as nuisance covariates.
Finally, for each significant analysis, we extracted the mean values of the DTI measures for each subject in the significant WM tracts were the signal peak was observed, selected through the JHU-ICBM-DTI label atlas. Then, we performed a regression analysis within the GLZM framework to evaluate the strength of the association of each significant imaging result (Supplementary information).
Results
The clinical and demographic characteristics of the sample are reported in Table 1. The mean and standard deviation of all the observed relative frequencies of the different cellular subpopulations obtained through FACS immunophenotyping are reported in Table 2. Patients with a depressive episode were younger, and with a younger age at onset of illness than patients with a manic episode. Cell frequencies were not significantly different among groups, correcting for age, sex, and age at onset of illness. The cell frequencies did not correlate with illness duration and number of episodes. In the whole sample with both depressed and manic patients, circulating cytotoxic T-cell frequencies and activation status were significantly associated with WM microstructure (Table 3). In general, compared to the whole panel analyzed, we observed that only the frequencies of Naïve, EM, and CM cells expressing Perforin and Granzyme were associated with measures of reduced WM integrity (reduced FA and/or increased RD and MD), while frequencies of Naïve and CM cells negative for Perforin and Granzyme associated with measures of better WM integrity (increased FA and reduced RD). More in detail, the cells that were associated with measures of WM integrity were CD8+ Naïve Perf−Grz− and CD3+CD8+EM Perf−Grz+ that positively associated with FA and negatively with RD; CD3+CD8+CM Perf−Grz− that negatively associated with RD and MD; CD3+CD8+TEMRA Perf−Grz+ that positively associated with FA measures. The cell subpopulations that were related to measures of reduced WM microstructural integrity were: CD3+CD8+Naïve Perf+Grz− and CD3+CD8+CM Perf−Grz+, which negatively associated with FA and positively associated with both RD and MD; CD3+CD8+Naïve Perf+Grz+, CD3+CD8+EM Perf+Grz−, CD3+CD8+CM Perf+Grz−, and CD3+CD8+TEMRA Perf+Grz− which negatively associated with FA and positively associated with RD; finally, CD3+CD8+CM, CD3+CD8+EM Perf+Grz+ and CD3+ CD8+CM Perf+Grz+ which resulted negatively associated with FA. No significant effect was observed on AD measures. NK and Tγδ cells were not related to structural brain measures.
Effects were spread in the WM skeleton for Naïve, EM (Fig. 1), CM, and TEMRA (Fig. 2) cells, with signal peaks observed in Thalamic Radiation, Corona Radiata, Corpus Callosum, Superior and Inferior Fronto-Occipital Fasciculus, Forceps Minor, Internal Capsule (see detailed summary of the results in Tables 2 and 3).
WM areas where CD3+CD8+EM and CD3+CD8+Naïve cells subpopulations percentage correlated with TBSS WM indexes. Voxels of significant negative correlation are mapped on the mean FA template of the studied sample. The colour-bar refers to 1 − p values for the observed differences. Numbers are z coordinates in the standard MNI space.
WM areas where CD3+CD8+CM cells and CD3+CD8+TEMRA cells subpopulations percentage correlated with TBSS WM indexes. Voxels of significant negative correlation are mapped on the mean FA template of the studied sample. The colour-bar refers to 1 − p values for the observed differences. Numbers are z coordinates in the standard MNI space.
Analyzing depressed patients separately did not change the observed results.
Discussion
The main finding of the present study is that differential expression of Perforin and Granzyme by CTLs is associated with in vivo measures of WM microstructure in patients with an active illness episode (depressive or manic) in the course of BD. While the frequency of naïve cells negative for both Perforin and Granzyme was associated with better WM integrity, frequencies of naïve and activated CD8+ cell populations positive for Perforin or both Perforin and Granzyme were negatively associated with WM microstructure. Effects were observed for measures associated with orientational coherence and myelination of the fibers (FA and RD) and not for measures associated with integrity and microtubular structure of the axons (AD), thus suggesting oligodendrocyte-mediated myelination as the main involved mechanism. The same results were confirmed in the depressive state subgroup. For this reason, it seems plausible to exclude, at this level, a possible effect of the episode (depressive or manic) in the relation between TBSS indexes and immune cell type. Moreover, this seems in line with the statistics analysis confirming no cell frequency differences among groups. For this reason, we will discuss the results reasoning on the whole group.
CD8+ T cells carry out cytotoxic activity, releasing killer proteins50. Within these toxins, Perforin and Granzyme are the most important to induce target cell death: the secretory granules migrate along the microtubule-organizing center and release their cytotoxic content in the synaptic cleft formed with the target cell51. Perforin is a glycoprotein able to polymerize and form a channel in the membranes of target cells. The opening of a channel disrupts the cell membrane and promotes cell death by affecting the integrity of the target cell52,53 and allowing the influx of Granzymes, thus inducing the activation of pro-apoptotic pathways and DNA degradation54,55. Animal studies showed that while knockout of Perforin abolished granule-dependent target cell death, disruption of granzyme genes had far smaller consequences56. Our results of a general pattern of lower FA and higher RD in association with cells expressing Perforin, and higher FA and lower RD in those not expressing Perforin and Granzyme, suggests that cell damage following CTLs activation may be a mechanism involved in disrupting WM microstructure in BD, with effects distributing along the gradient of toxins expression (Fig. 3).
Summary of the Perforin/Granzyme mechanistic hypothesis for CD8+ T cells immune-related WM damage in BD. It is surmised that the release of Perforin by CTLs could cause a damage to oligodendrocytes, worsened by Granzyme, while Granzyme alone could induce a minor damage; and while the frequency of CD8+ T naïve cells not expressing toxins associates with preserved WM integrity.
The activation status of the cells could interact with toxins expression in influencing WM microstructure. CM cells, but not EM and Naïve cells, are associated to negative effects (reduced FA, increased MD and RD) also when only Granzyme is expressed. During an inflammatory response, EM cells show faster effector properties and represent the first line against pathogens, while CM show higher proliferative potential and differentiate into new effectors to maintain the immune response's efficiency57. CD8+ CM cells secreting cytolytic molecules after restimulation exert a potent effector function58 and have a great migratory response, leading to strategic positioning at pathogens entering sites or damage location59. CD8+ CM cells are also able to self-renewal and re-expansion60, and to prompt activation of Naïve CD861. Granzymes can directly influence inflammation62 either by directly activating the proinflammatory cytokine IL-1β63 or by activating macrophages to secrete cytokines64, and can then contribute to immune-neurotoxicity, excitation, and autoimmunity in the brain65,66. Sustained production of Granzyme by CM cells could then be possibly sufficient to trigger inflammatory mechanisms, which have been associated with WM damage in BD31,67, while Perforin could also be necessary to cause the damage associated with Naïve, EM, and TEMRA cells.
These findings seem, therefore, to support the hypothesis that CD8+ T cells can leave the bloodstream to migrate into the brain and induce immune-related WM damage in BD38. This mechanism has been described in other conditions associated with WM damage. CD8+ T cells are the most prevailing lymphocyte population in inflammatory lesions of patients with multiple sclerosis68, and it has been long known that oligodendrocytes are vulnerable to attack by Perforin, which may cause transient or irreversible myelin injury69. CTLs play a core role in limbic encephalitis70, and animal models confirmed that they can attack oligodendrocytes71, particularly in the presence of brain infection72, but also cause sclerosis-like lesions by recognizing antigens on oligodendrocytes73. It is widely recognized that CD8+ T cells contribute to the initiation, progression, and regulation of several human pathogenic autoimmune responses74. Recently, Magioncalda and Martino proposed an interesting model suggesting that immune alterations in BD patients may represent the preeminent pathophysiological mechanisms underpinning WM microstructural modifications, especially in the limbic circuit75. The immune-mediated WM damage involving the connections within the limbic network would destabilize the neurotransmitter signaling by promoting functional alterations of the neurotransmitter-related nuclei, leading to phasic reconfigurations of intrinsic brain activity. These phasic changes in the activity of brain regions within the limbic network would then manifest as the changes in mood and emotion processing characteristically observed in BD75. In agreement with this model, we observed that, irrespective of the illness phase, immune cell populations associated with WM microstructure in several fiber tracts that connect the limbic system with other brain regions, such as the corpus callosum, which connects, amongst others, the anterior cingulate cortex and orbitofrontal cortex playing an essential role in mood regulation76; and the corona radiata and the thalamic radiation which are part of the limbic-thalamo-cortical circuitry and also plays an important role in emotion regulation77.
Post-mortem studies in patients with BD detected apoptotic markers in limbic and prefrontal regions78,79, where the density of neurons and glia were decreased80. Blood–brain barrier dysfunction has been associated with BD, with leakage predicting more severe illness outcomes81. A single, pivotal post-mortem study in patients with mood disorders or schizophrenia described diffuse brain cortical and subcortical infiltration by CD8+ T cells in 4 out of 9 patients with BD11: if this happens during active illness episodes, or is a trait of the illness, remains unknown. Studies in inflammatory conditions with brain damage and CD8+ involvement, such as multiple sclerosis, reported lower frequencies of circulating CD8+ T cells, paralleling immune activation, autoreactivity, and susceptibility to infections82. A tempting hypothesis, formulated in early studies about WM damage in BD but still to be explored in longitudinal studies of patients in euthymic conditions, is that the waxing and waning of illness phases and inflammation, associated with BD, may parallel a pattern of immune-cell mediated WM damage associated with active illness phases12. Here cells frequencies are not associated with the number of episodes and illness duration: for this reason, it seems plausible that an inflammatory process is related to the disorder itself, rather than the severity measured as episode number and duration. This seems to be supported by previous findings reporting alterted inflammatory indexes already in adolescents with BD83, and not only in adults or patients with years of illness durations.
Finally, the counts of CD8+ Naïve cells negative for Granzyme and Perforin, and total CD8+CM cells irrespective of toxins expression, had opposite effects on FA: positive for Naïve cells, also associated with a reduction of RD, and negative for CM cells. An expansion of senescence-associated cells (CD8+ CD28−) in BD84 has been reported in the frame of a lifetime pattern of reduction of naïve T cells with expansion of memory and senescent T cells2,3,4,5,6. We did not study specific senescence markers, but the finding of a positive effect of Naïve cells on WM integrity, paired with a detrimental effect of CM, suggests that immune-senescence correlates with WM microstructure in BD. Supporting this hypothesis of WM alterations related to lymphocyte cytotoxic activity associated with senescence, Moreno-Valladares, and colleagues found a low-grade infiltration of CD3+ and CD8+ lymphocytes in WM of post-mortem brain of healthy donors, with increased infiltration in elderly subjects (65–87 years) compared to younger (36–58 years) individuals85. Moreover, Magioncalda and colleagues compared the association of characterized CD4 and CD8 cell levels with WM integrity index in healthy controls and BD patients86. They found an association between FA and RD measured in the body of the corpus callosum and superior corona radiata only in the manic subgroup of BD patients, where no association was found for HC. Despite our lack of a control group, based on these other findings, we can argue that the baseline differences between HC and BD patients in lymphocytes and CD8 subpopulation levels87, significantly associated with measures of WM integrity only in BD patients, thus supporting the idea of a detrimental effect of cytotoxic lymphocytes infiltration in brain of BD patients. Surely, due to the associative nature of MRI studies, the hypothesis of a specific association of cytotoxic CD8 cells and WM measures in BD needs to be tested in future studies, also assessing specific senescence markers.
Strengths of the present study include a focused research question and state-of-the-art imaging methods, but our results must be viewed in light of some limitations. The lack of a healthy control group for DTI limits generalizability to the general population and hampers the possibility of fully understanding immune cell abnormalities and their association with WM microstructure, future studies should address this issue. No patient was drug-naive, and the drug treatments administered during the course of the illness, including antidepressant and antipsychotic drugs, could have influenced MRI measures. Recruitment was in a single center and in a single ethnic group, thus raising the possibility of population stratification. The findings are associative, and a possible causal effect of cytotoxic T-lymphocyte subpopulations must be investigated in experimental settings (e.g., animal studies and or in vitro studies) capable of showing causative relations. These limitations, however, do not bias the main finding of an effect of circulating CD8+ cytotoxic cell count on WM integrity in BD, thus providing new insight into possible pathogenetic mechanisms and targets for treatment.
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Benedetti, F., Aggio, V., Pratesi, M. L., Greco, G. & Furlan, R. Neuroinflammation in bipolar depression. Front. Psych. 11, 71 (2020).
Poletti, S. et al. Th17 cells correlate positively to the structural and functional integrity of the brain in bipolar depression and healthy controls. Brain. Behav. Immun. 61, 317–325. https://doi.org/10.1016/j.bbi.2016.12.020 (2017).
Swallow, V. M. et al. Multidisciplinary teams, and parents, negotiating common ground in shared-care of children with long-term conditions: A mixed methods study. BMC Health Serv. Res. 13, 264. https://doi.org/10.1186/1472-6963-13-264 (2013).
Becking, K. et al. The circulating levels of CD4+ t helper cells are higher in bipolar disorder as compared to major depressive disorder. J. Neuroimmunol. 319, 28–36. https://doi.org/10.1016/j.jneuroim.2018.03.004 (2018).
Bauer, M. E., Wieck, A., Petersen, L. E. & Baptista, T. S. Neuroendocrine and viral correlates of premature immunosenescence. Ann. N. Y. Acad. Sci. 1351, 11–21 (2015).
Simon, M. S. et al. Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression. Prog. Neuro Psychopharmacol. Biol. Psychiatry 111, 110391 (2021).
Benedetti, F., Aggio, V., Pratesi, M. L., Greco, G. & Furlan, R. Neuroinflammation in bipolar depression. Front. Psychiatry 11, 71. https://doi.org/10.3389/fpsyt.2020.00071 (2020).
Rosenblat, J. D. & McIntyre, R. S. Bipolar disorder and immune dysfunction: epidemiological findings, proposed pathophysiology and clinical implications. Brain Sci. https://doi.org/10.3390/brainsci7110144 (2017).
Haroon, E., Miller, A. H. & Sanacora, G. Inflammation, glutamate, and glia: A trio of trouble in mood disorders. Neuropsychopharmacology 42, 193–215 (2017).
Liu, S.-H., Du, Y., Chen, L. & Cheng, Y. Glial cell abnormalities in major psychiatric diseases: A systematic review of postmortem brain studies. Mol. Neurobiol. 59, 1665–1692 (2022).
Schlaaff, K. et al. Increased densities of T and B lymphocytes indicate neuroinflammation in subgroups of schizophrenia and mood disorder patients. Brain Behav. Immun. 88, 497–506 (2020).
Benedetti, F. et al. Disruption of white matter integrity in bipolar depression as a possible structural marker of illness. Biol. Psychiatry 69, 309–317. https://doi.org/10.1016/j.biopsych.2010.07.028 (2011).
Benedetti, F. & Bollettini, I. Recent findings on the role of white matter pathology in bipolar disorder. Harv. Rev. Psychiatry 22, 338–341. https://doi.org/10.1097/HRP.0000000000000007 (2014).
Marlinge, E., Bellivier, F. & Houenou, J. White matter alterations in bipolar disorder: potential for drug discovery and development. Bipolar. Disord. 16, 97–112. https://doi.org/10.1111/bdi.12135 (2014).
Heng, S., Song, A. W. & Sim, K. White matter abnormalities in bipolar disorder: Insights from diffusion tensor imaging studies. J. Neural. Transm. 117, 639–654. https://doi.org/10.1007/s00702-010-0368-9 (2010).
Chaddock, C. A. et al. White matter microstructural impairments and genetic liability to familial bipolar I disorder. Br. J. Psychiatry 194, 527–534. https://doi.org/10.1192/bjp.bp.107.047498 (2009).
Whalley, H. C. et al. Polygenic risk and white matter integrity in individuals at high risk of mood disorder. Biol. Psychiatry https://doi.org/10.1016/j.biopsych.2013.01.027 (2013).
Benedetti, F. et al. Adverse childhood experiences influence white matter microstructure in patients with bipolar disorder. Psychol. Med. 44, 3069–3082. https://doi.org/10.1017/S0033291714000506 (2014).
Bollettini, I. et al. Clock genes associate with white matter integrity in depressed bipolar patients. Chronobiol. Int. 34, 212–224. https://doi.org/10.1080/07420528.2016.1260026 (2017).
Benedetti, F. et al. White matter microstructure in bipolar disorder is influenced by the serotonin transporter gene polymorphism 5-HTTLPR. Genes Brain Behav. 14, 238–250. https://doi.org/10.1111/gbb.12206 (2015).
Benedetti, F. et al. A Homer 1 gene variant influences brain structure and function, lithium effects on white matter, and antidepressant response in bipolar disorder: A multimodal genetic imaging study. Prog. Neuropsychopharmacol. Biol. Psychiatry 81, 88–95. https://doi.org/10.1016/j.pnpbp.2017.10.011 (2018).
Matsuo, K. et al. Anterior genu corpus callosum and impulsivity in suicidal patients with bipolar disorder. Neurosci. Lett. 469, 75–80. https://doi.org/10.1016/j.neulet.2009.11.047 (2010).
Poletti, S. et al. Cognitive performances associate with measures of white matter integrity in bipolar disorder. J. Affect. Disord. 174, 342–352. https://doi.org/10.1016/j.jad.2014.12.030 (2015).
Oertel-Knochel, V. et al. Frontal white matter alterations are associated with executive cognitive function in euthymic bipolar patients. J. Affect. Disord. 155, 223–233. https://doi.org/10.1016/j.jad.2013.11.004 (2014).
Bollettini, I. et al. Disruption of white matter integrity marks poor antidepressant response in bipolar disorder. J. Affect. Disord. 174, 233–240. https://doi.org/10.1016/j.jad.2014.11.010 (2015).
Schwartz, M. & Cahalon, L. The vicious cycle governing the brain–immune system relationship in neurodegenerative diseases. Curr. Opin. Immunol. 76, 102182 (2022).
Drexhage, R. C. et al. The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder. Expert Rev. Neurother. 10, 59–76. https://doi.org/10.1586/ern.09.144 (2010).
Benedetti, F. et al. Neural and genetic correlates of antidepressant response to sleep deprivation—A functional magnetic resonance imaging study of moral valence decision, in bipolar depression. Arch. Gen. Psychiatry 64, 179–187. https://doi.org/10.1001/archpsyc.64.2.179 (2007).
Furlan, R. et al. Natural killer cells protect white matter integrity in bipolar disorder. Brain Behav. Immun. 81, 410–421 (2019).
Benedetti, F. et al. Lithium and GSK3-beta promoter gene variants influence white matter microstructure in bipolar disorder. Neuropsychopharmacology 38, 313–327. https://doi.org/10.1038/npp.2012.172 (2013).
Benedetti, F. et al. Inflammatory cytokines influence measures of white matter integrity in Bipolar Disorder. J. Affect. Disord. 202, 1–9. https://doi.org/10.1016/j.jad.2016.05.047 (2016).
Tedeschi, V. et al. CD8+ T cell senescence: Lights and shadows in viral infections, autoimmune disorders and cancer. Int. J. Mol. Sci. 23, 3374 (2022).
Becking, K. et al. The circulating levels of CD4+ t helper cells are higher in bipolar disorder as compared to major depressive disorder. J. Neuroimmunol. 319, 28–36 (2018).
Barbosa, I. G. et al. Monocyte and lymphocyte activation in bipolar disorder: A new piece in the puzzle of immune dysfunction in mood disorders. Int. J. Neuropsychopharmacol. https://doi.org/10.1093/ijnp/pyu021 (2014).
Pietruczuk, K. et al. Peripheral blood lymphocyte subpopulations in patients with bipolar disorder type II. Sci. Rep. 9, 1–9 (2019).
Maes, M. et al. Impairments in peripheral blood T effector and T regulatory lymphocytes in bipolar disorder are associated with staging of illness and anti-cytomegalovirus IgG levels. Mol. Neurobiol. 58, 229–242 (2021).
Rizzo, L. B. et al. An immunological age index in bipolar disorder: A confirmatory factor analysis of putative immunosenescence markers and associations with clinical characteristics. Int. J. Methods Psychiatric Res. 27, e1614 (2018).
Magioncalda, P. et al. White matter microstructure alterations correlate with terminally differentiated CD8+ effector T cell depletion in the peripheral blood in mania: Combined DTI and immunological investigation in the different phases of bipolar disorder. Brain Behav. Immun. 73, 192–204 (2018).
Meuth, S. G. et al. Cytotoxic CD8+ T cell–neuron interactions: perforin-dependent electrical silencing precedes but is not causally linked to neuronal cell death. J. Neurosci. 29, 15397–15409 (2009).
Hamilton, M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6, 278–296. https://doi.org/10.1111/j.2044-8260.1967.tb00530.x (1967).
Young, R. C., Biggs, J. T., Ziegler, V. E. & Meyer, D. A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 133, 429–435. https://doi.org/10.1192/bjp.133.5.429 (1978).
Beck, A. T. & Steer, R. A. Beck Depression Inventory Manual (Psychological Corporation, 1993).
McCullagh, P. & Nelder, J. A. Generalized Linear Models 2nd edn. (Chapman & Hall, 1989).
Agresti, A. An Introduction to Categorical Data Analysis (Wiley, 1996).
Dobson, A. J. An Introduction to Generalized Linear Models (Chapman & Hall, 1990).
Smith, S. M. et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23(Suppl 1), S208-219. https://doi.org/10.1016/j.neuroimage.2004.07.051 (2004).
Smith, S. M. et al. Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. Neuroimage 31, 1487–1505. https://doi.org/10.1016/j.neuroimage.2006.02.024 (2006).
Kochunov, P. et al. Relationship between white matter fractional anisotropy and other indices of cerebral health in normal aging: Tract-based spatial statistics study of aging. Neuroimage 35, 478–487. https://doi.org/10.1016/j.neuroimage.2006.12.021 (2007).
Herting, M. M., Maxwell, E. C., Irvine, C. & Nagel, B. J. The impact of sex, puberty, and hormones on white matter microstructure in adolescents. Cereb. Cortex https://doi.org/10.1093/cercor/bhr246 (2011).
Voskoboinik, I., Whisstock, J. C. & Trapani, J. A. Perforin and granzymes: function, dysfunction and human pathology. Nat. Rev. Immunol. 15, 388–400 (2015).
Ritter, A. T., Angus, K. L. & Griffiths, G. M. The role of the cytoskeleton at the immunological synapse. Immunol. Rev. 256, 107–117. https://doi.org/10.1111/imr.12117 (2013).
Liu, C. C., Young, L. H. & Young, J. D. Lymphocyte-mediated cytolysis and disease. N. Engl. J. Med. 335, 1651–1659. https://doi.org/10.1056/NEJM199611283352206 (1996).
Trapani, J. A. Target cell apoptosis induced by cytotoxic T cells and natural killer cells involves synergy between the pore-forming protein, perforin, and the serine protease, granzyme B. Aust. N. Z. J. Med. 25, 793–799 (1995).
Law, R. H. et al. The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature 468, 447–451. https://doi.org/10.1038/nature09518 (2010).
Lopez, J. A. et al. Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack. Blood 121, 2659–2668. https://doi.org/10.1182/blood-2012-07-446146 (2013).
Voskoboinik, I., Whisstock, J. C. & Trapani, J. A. Perforin and granzymes: Function, dysfunction and human pathology. Nat. Rev. Immunol. 15, 388–400. https://doi.org/10.1038/nri3839 (2015).
Pennock, N. D. et al. T cell responses: Naive to memory and everything in between. Adv. Physiol. Educ. 37, 273–283. https://doi.org/10.1152/advan.00066.2013 (2013).
Parga-Vidal, L. & van Gisbergen, K. Area under immunosurveillance: Dedicated roles of memory CD8 T-cell subsets. Cold Spring Harb. Perspect. Biol. https://doi.org/10.1101/cshperspect.a037796 (2020).
Kastenmuller, W. et al. Peripheral prepositioning and local CXCL9 chemokine-mediated guidance orchestrate rapid memory CD8+ T cell responses in the lymph node. Immunity 38, 502–513. https://doi.org/10.1016/j.immuni.2012.11.012 (2013).
Graef, P. et al. Serial transfer of single-cell-derived immunocompetence reveals stemness of CD8(+) central memory T cells. Immunity 41, 116–126. https://doi.org/10.1016/j.immuni.2014.05.018 (2014).
Sasaki, K. et al. Activated-memory T cells influence naive T cell fate: a noncytotoxic function of human CD8 T cells. Commun. Biol. 5, 1–15 (2022).
Metkar, S. S. et al. Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity 29, 720–733. https://doi.org/10.1016/j.immuni.2008.08.014 (2008).
Irmler, M. et al. Granzyme A is an interleukin 1 beta-converting enzyme. J. Exp. Med. 181, 1917–1922. https://doi.org/10.1084/jem.181.5.1917 (1995).
Sower, L. E. et al. Extracellular activities of human granzyme A. Monocyte activation by granzyme A versus alpha-thrombin. J. Immunol. 156, 2585–2590 (1996).
Gahring, L., Carlson, N. G., Meyer, E. L. & Rogers, S. W. Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated by glycosylation. J. Immunol. 166, 1433–1438. https://doi.org/10.4049/jimmunol.166.3.1433 (2001).
Ganor, Y., Teichberg, V. I. & Levite, M. TCR activation eliminates glutamate receptor GluR3 from the cell surface of normal human T cells, via an autocrine/paracrine granzyme B-mediated proteolytic cleavage. J. Immunol. 178, 683–692. https://doi.org/10.4049/jimmunol.178.2.683 (2007).
Poletti, S. et al. Pro-inflammatory cytokines predict brain metabolites concentrations in the anterior cingulate cortex of patients with bipolar disorder. Front. Psychiatry 11, 1364 (2020).
Konjevic Sabolek, M. et al. Communication of CD 8+ T cells with mononuclear phagocytes in multiple sclerosis. Ann. Clin. Trans. Neurol. 6, 1151–1164 (2019).
Scolding, N. J., Jones, J., Compston, D. A. & Morgan, B. P. Oligodendrocyte susceptibility to injury by T-cell perforin. Immunology 70, 6–10 (1990).
Ehling, P., Melzer, N., Budde, T. & Meuth, S. G. CD8+ T cell-mediated neuronal dysfunction and degeneration in limbic encephalitis. Front Neurol. 6, 163 (2015).
Melzer, N. et al. Excitotoxic neuronal cell death during an oligodendrocyte-directed CD8+ T cell attack in the CNS gray matter. J. Neuroinflamm. 10, 1–13 (2013).
Na, S.-Y. et al. Oligodendrocytes enforce immune tolerance of the uninfected brain by purging the peripheral repertoire of autoreactive CD8+ T cells. Immunity 37, 134–146 (2012).
Saxena, A. et al. Cutting edge: Multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J. Immunol. 181, 1617–1621 (2008).
Walter, U. & Santamaria, P. CD8+ T cells in autoimmunity. Curr. Opin. Immunol. 17, 624–631 (2005).
Magioncalda, P. & Martino, M. A unified model of the pathophysiology of bipolar disorder. Mol. Psychiatry 27, 202–211. https://doi.org/10.1038/s41380-021-01091-4 (2022).
Pico-Perez, M., Radua, J., Steward, T., Menchon, J. M. & Soriano-Mas, C. Emotion regulation in mood and anxiety disorders: A meta-analysis of fMRI cognitive reappraisal studies. Prog. Neuropsychopharmacol. Biol. Psychiatry 79, 96–104. https://doi.org/10.1016/j.pnpbp.2017.06.001 (2017).
Drevets, W. C., Price, J. L. & Furey, M. L. Brain structural and functional abnormalities in mood disorders: Implications for neurocircuitry models of depression. Brain Struct. Funct. 213, 93–118. https://doi.org/10.1007/s00429-008-0189-x (2008).
Savitz, J. B., Price, J. L. & Drevets, W. C. Neuropathological and neuromorphometric abnormalities in bipolar disorder: View from the medial prefrontal cortical network. Neurosci. Biobehav. Rev. 42, 132–147. https://doi.org/10.1016/j.neubiorev.2014.02.008 (2014).
Mechawar, N. & Savitz, J. Neuropathology of mood disorders: do we see the stigmata of inflammation?. Transl. Psychiatry 6, e946. https://doi.org/10.1038/tp.2016.212 (2016).
Bauer, M. E. & Teixeira, A. L. Neuroinflammation in mood disorders: role of regulatory immune cells. Neuroimmunomodulation 28, 99–107. https://doi.org/10.1159/000515594 (2021).
Kamintsky, L. et al. Blood-brain barrier imaging as a potential biomarker for bipolar disorder progression. NeuroImage Clin. 26, 102049 (2020).
Jones, A. P. et al. Circulating immune cells in multiple sclerosis. Clin. Exp. Immunol. 187, 193–203 (2017).
Karthikeyan, S. et al. Inflammatory markers, brain-derived neurotrophic factor, and the symptomatic course of adolescent bipolar disorder: A prospective repeated-measures study. Brain Behav. Immun. 100, 278–286. https://doi.org/10.1016/j.bbi.2021.11.020 (2022).
do Prado, C. H. et al. Reduced regulatory T cells are associated with higher levels of Th1/TH17 cytokines and activated MAPK in type 1 bipolar disorder. Psychoneuroendocrinology 38, 667–676 (2013).
Moreno-Valladares, M. et al. CD8(+) T cells are present at low levels in the white matter with physiological and pathological aging. Aging 12, 18928–18941. https://doi.org/10.18632/aging.104043 (2020).
Magioncalda, P. et al. White matter microstructure alterations correlate with terminally differentiated CD8+ effector T cell depletion in the peripheral blood in mania: Combined DTI and immunological investigation in the different phases of bipolar disorder. Brain Behav. Immun. 73, 192–204. https://doi.org/10.1016/j.bbi.2018.04.017 (2018).
Pietruczuk, K. et al. Peripheral blood lymphocyte subpopulations in patients with bipolar disorder type II. Sci. Rep. 9, 5869. https://doi.org/10.1038/s41598-019-42482-6 (2019).
Funding
European Union H2020 Grant 754740 "MOODSTRATIFICATION: Immune Signatures for Therapy Stratification in Major Mood Disorders" (FB, SP, LF, RF). Italian Ministry of University, XXXIV PhD cycle (VA).
Author information
Authors and Affiliations
Contributions
F.B. wrote the research project; F.B. and R.F., has been granted funding for the research project and oversaw all the experiments and analysis; V.A. and L.F. performed laboratory experiments; V.A. performed neuroimaging and statistical analysis; L.C., A.F., oversaw laboratory experiments; C.C., F.B. and R.Z. oversaw patients recruitment. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Aggio, V., Fabbella, L., Poletti, S. et al. Circulating cytotoxic immune cell composition, activation status and toxins expression associate with white matter microstructure in bipolar disorder. Sci Rep 13, 22209 (2023). https://doi.org/10.1038/s41598-023-49146-6
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-023-49146-6





